期刊文献+

Tumor microenvironment-responsive drug self-delivery systems to treat cancer and overcome MDR

原文传递
导出
摘要 Tumor microenvironment-responsive drug self-delivery systems utilize tumor microenvironment-responsive chemical bonds to link anti-tumor drugs,exploiting the hydrophilic and hydrophobic properties of different drugs to form amphiphilic prodrug molecules with self-assembly characteristics.Upon stimulation by specific factors in the tumor microenvironment,these amphiphilic prodrug molecules can release drugs at precise sites within the tumor.These strategies significantly increase the drug concentration at the tumor site while effectively reducing the damage of anti-cancer drugs to normal tissues.Owing to the advanced delivery strategies such as synergistic administration and controlled drug release,tumor microenvironment-responsive drug self-delivery systems hold great potential for treating malignant tumors with multidrug resistance(MDR).At the same time,the stimulus-reactivity of metal complexes provides an important opportunity to design site-specific prodrugs that can maximize therapeutic efficacy while minimizing adverse side effects of metal drugs.This innovative drug design complements the tumor microenvironment-responsive self-delivery system,providing more feasible therapeutic strategies and possibilities in the field of cancer therapy and drug delivery.This work provides a comprehensive review of recent advancements in drug self-delivery systems,offering insights into their potential applications in cancer therapy and MDR reversal.
出处 《Rare Metals》 2025年第1期1-33,共33页 稀有金属(英文版)
基金 supported by the National Natural Science Foundation of China(No.21907059) Shandong Province Chinese Medicine Science and Technology Development Project(No.M-2022258) the Young Scientist Development Foundation of Shandong First Medical University(No.202201-002) the Academic Promotion Program of Shandong First Medical University(Nos.2019LJ003 and 2019QL011).
  • 相关文献

参考文献4

二级参考文献32

  • 1Naldini L. Nature, 2015, 526:351-360.
  • 2Wu MY, Meng QS, Chen Y, Du YY, Zhang LX, Li YP, Zhang, LL. Shi JL. Adv Mater, 2015, 27:215-222.
  • 3Yan H, Oornmen OP, Yu D, Hilborn J, Qian H, Varghese OP. Adv Funct Mater, 2015, 25:3907-3915.
  • 4Wu ZY, Zhan SY, Fan W, Ding XY, Wu X, Zhang W, Fu YH, Huang YY, Huang X, Chert RB, Li MJ, Xu NY, Zheng YX, Ding BY Nanoscale Res Lett, 2016, 11:1-13.
  • 5Klauber TCB, Sndergaard RV, Sawant RR, Torchilin VP, Andresen TL. Acta Biomaterialia, 2016, 35:248-259.
  • 6Wang RR, Hu H, Cai Q, Zhao NN, Zhu Y, Xu FJ. Sci China Chem, 2015, 58:1461-1470.
  • 7Liu C, Liu F, Feng L, Li M, Zhang J, Zhang N. Biomaterials, 2013, 34:2547-2564.
  • 8Jia HZ, Luo XH, Cheng H, Yang J, Li C, Liu CW, Feng J, Zhang XZ, Zhuo RX. JMater Chem, 2012, 22:24092-24101.
  • 9Li J, Wang Y, Zhu Y, Oupick D. J Control Release, 2013, 172: 589-600.
  • 10Lei C, Cui Y, Zheng L, Kah-Hoe Chow P, Wang CH. Biomaterials, 2013, 34:7483-7494.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部